InvestorsObserver
×
News Home

Is Altimmune Inc (ALT) a Good Choice in Biotechnology Thursday?

Thursday, December 01, 2022 12:11 PM | InvestorsObserver Analysts

Mentioned in this article

Is Altimmune Inc (ALT) a Good Choice in Biotechnology Thursday?

Altimmune Inc (ALT) is near the top in its industry group according to InvestorsObserver. ALT gets an overall rating of 60. That means it scores higher than 60 percent of stocks. Altimmune Inc gets a 74 rank in the Biotechnology industry. Biotechnology is number 63 out of 148 industries.

Overall Score - 60
ALT has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on ALT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 60 would rank higher than 60 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Altimmune Inc Stock Today?

Altimmune Inc (ALT) stock is trading at $10.76 as of 12:01 PM on Thursday, Dec 1, an increase of $0.81, or 8.14% from the previous closing price of $9.95. The stock has traded between $10.23 and $10.85 so far today. Volume today is light. So far 554,866 shares have traded compared to average volume of 1,103,773 shares. Click Here to get the full Stock Report for Altimmune Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App